Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Vibhavadi Medical Center Public Company Limited (VIBHA.BK)
THB1.36
+0.00 (+0.00%)
TH SET Healthcare Medical - Care Facilities
Address
51/3 Ngam Wong Wan Road 10900
Bangkok, TH
Bangkok, TH
CEO
Chaisith Viriyamettakul
Website
vibhavadi.com
IPO
2000-01-20
ISIN TH0295A10Z07
Description
Vibhavadi Medical Center Public Company Limited, a Bangkok, Thailand-based entity, manages Vibhavadi Hospital. Its operations are divided into two main segments: Hospital services and other ventures. The company delivers a full spectrum of medical care, supplemented by hotel and room rental accommodations. It also participates in the beauty industry. This firm was established in 1986.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
THB1.36
+0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
663.9K
Beta
-0.04
Float Shares
3.39B
Free Float %
25.2%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.74% | +0.74% | -1.44% | -2.84% | -2.84% | -2.14% | -13.29% | -46.06% | -35.98% | -49.26% | +360.06% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
1.36
DCF (Unlevered)
0.95
-30.3%
DCF (Levered)
1.09
-19.5%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2025-03 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
1.82
Grey zone
Piotroski F-Score
5 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
4 / 5
High
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
2 / 5
Medium
P/E Score
3 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%-34.3% Q1'26: -36.4% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+151.5% ★ Q1'26: +431.6% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+6.2% Q1'26: +4.9% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+11.5% ★ Q1'26: +8.0% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+3.4% Q1'26: +2.0% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%-0.3% ★ Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×6.97× Q1'26: 8.10× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
5.40B
est: 5.89B (-8.4%)
|
5.76B
est: 5.76B (0.0%)
|
6.10B
est: 6.10B (+0.0%)
|
6.47B
est: 6.60B (-1.9%)
|
6.55B
est: 6.75B (-3.0%)
|
6.02B
est: 5.88B (+2.4%)
|
7.40B
est: 7.08B (+4.4%)
|
8.61B
est: 8.28B (+4.0%)
|
8.17B
est: 8.64B (-5.4%)
|
8.55B
est: 8.52B (+0.3%)
|
5.62B
est: 8.95B (-37.2%)
|
5.36B
5.36B – 5.36B
-40.1% YoY
|
| EBITDA |
1.54B
est: 1.57B (-2.1%)
|
1.58B
est: 1.54B (+2.9%)
|
1.81B
est: 1.63B (+11.2%)
|
1.62B
est: 1.76B (-8.0%)
|
1.55B
est: 1.80B (-13.8%)
|
1.36B
est: 1.57B (-13.4%)
|
2.20B
est: 1.89B (+16.1%)
|
2.65B
est: 2.21B (+19.9%)
|
2.22B
est: 2.25B (-1.0%)
|
1.99B
est: 2.22B (-10.2%)
|
1.07B
est: 2.33B (-54.1%)
|
1.39B
1.39B – 1.39B
-40.1% YoY
|
| EBIT |
1.26B
est: 1.15B (+9.5%)
|
1.21B
est: 1.13B (+7.8%)
|
1.41B
est: 1.19B (+18.7%)
|
1.23B
est: 1.29B (-5.0%)
|
1.14B
est: 1.32B (-13.5%)
|
946.92M
est: 1.15B (-17.6%)
|
1.70B
est: 1.38B (+22.7%)
|
2.06B
est: 1.62B (+27.5%)
|
1.58B
est: 1.62B (-2.3%)
|
1.35B
est: 1.59B (-15.4%)
|
644.98M
est: 1.67B (-61.4%)
|
1.00B
1.00B – 1.00B
-40.1% YoY
|
| Net Income |
735.65M
est: 736.85M (-0.2%)
|
678.64M
est: 584.80M (+16.0%)
|
868.55M
est: 1.17B (-25.7%)
|
723.67M
est: 701.77M (+3.1%)
|
809.05M
est: 1.17B (-30.8%)
|
465.47M
est: 891.14M (-47.8%)
|
1.81B
est: 1.49B (+21.3%)
|
1.34B
est: 1.35B (-0.9%)
|
865.12M
est: 617.21M (+40.2%)
|
698.61M
est: 1.01B (-30.9%)
|
1.69B
est: 539.39M (+214.2%)
|
674.23M
674.23M – 674.23M
+25.0% YoY
|
| SGA |
746.64M
est: 842.32M (-11.4%)
|
860.21M
est: 823.58M (+4.4%)
|
870.98M
est: 872.49M (-0.2%)
|
915.85M
est: 944.15M (-3.0%)
|
953.47M
est: 965.18M (-1.2%)
|
925.04M
est: 841.60M (+9.9%)
|
946.31M
est: 1.01B (-6.6%)
|
1.09B
est: 1.18B (-8.0%)
|
1.19B
est: 1.26B (-5.5%)
|
1.39B
est: 1.24B (+11.8%)
|
927.69M
est: 1.30B (-28.7%)
|
778.95M
778.95M – 778.95M
-40.1% YoY
|
| EPS |
0.06
est: 0.05 (+7.4%)
|
0.05
est: 0.04 (+23.2%)
|
0.07
est: 0.09 (-23.7%)
|
0.05
est: 0.05 (-5.8%)
|
0.06
est: 0.09 (-29.2%)
|
0.03
est: 0.07 (-47.3%)
|
0.13
est: 0.11 (+18.2%)
|
0.10
est: 0.10 (-1.3%)
|
0.06
est: 0.05 (+39.2%)
|
0.05
est: 0.08 (-31.1%)
|
0.13
est: 0.04 (+225.0%)
|
0.05
0.05 – 0.05
+25.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-19 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-18 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-15 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-14 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-13 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-12 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-11 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-08 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-07 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-06 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-05 | A | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-29 | A | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-28 | A | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-27 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-24 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-2.57B
OE per share TTM
-0.19
Owner's Yield
-13.92%
Maintenance CapEx ratio
247.66%
Maint CapEx / Avg PPE
107.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
773.4K
Shares Outstanding
13.48B
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Phijit Wiriyamettakul | Managing Director & Director | 525.0K | male |
| Chaisith Viriyamettakul | Chairman of Executive Board, MD & Director | 525.0K | male |
| Sitthi Panupattanapong | Executive Director | 525.0K | male |
| Yada Puthkayon | Executive Director | 525.0K | female |
| Bavornphan Rathprasert | Company Secretary & Director | 525.0K | female |
| Natinee Chumnankijkosol | Head of Investor Relations | — | female |
| Sasithorn Norakrai | Company Secretary & Vice President of General Administration | — | female |
| Yongyut Domsuriya | Director of Finance and Accounting | — | male |
| Chaiyasith Kupwiwat | Hospital Director | — | — |
| Ladawan Inthravichai | Company Secretary & Head of Compliance Unit | — | female |
| Lieutenant General Promphong Pheerabul | Executive Vice President | — | — |
| Mingpimuk Lymcharounsa | Head of Internal Audit Department | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for VIBHA.BK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
